Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.9701
-0.0099 (-1.01%)
At close: Dec 4, 2025, 4:00 PM EST
1.010
+0.057 (5.98%)
Pre-market: Dec 5, 2025, 6:00 AM EST
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $26.26 million as of December 5, 2025. Its market cap has decreased by -65.91% in one year.
Market Cap
26.26M
Enterprise Value
26.51M
1-Year Change
-65.91%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $26.26M, a decrease of -92.41%. That is a compound annual growth rate of -43.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 25.79M | -67.80% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | 346.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |